Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Patient Satisfaction 1Neutropenia 1Leiomyoma 1Central Line-associated Bloodstream Infection (CLABSI) 1Benign Female Reproductive System Neoplasm 1

Interventions

Filgrastim 7pegylated granulocyte colony-stimulating factor 5pegfilgrastim 5Cytarabine 4Ciprofloxacin 4Cefepime 4Vancomycin 3Leucovorin 3Fluorouracil 3Amikacin 3trifluridine tipiracil drug combination 2Piperacillin, Tazobactam Drug Combination 2Methylprednisolone 2Meropenem 2Irinotecan 2Etoposide 2Daptomycin 2Cisplatin 2Ceftazidime 2ziprasidone 1trilaciclib 1sargramostim 1niraparib 1liposomal amphotericin B 1lintuzumab 1leridistim 1isavuconazole 1fludarabine phosphate 1flt3 ligand protein 1fish oil triglycerides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neutropenia × Vascular Access Devices × Clear all
NCT02967341 2016-11-18

Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients

Universitair Ziekenhuis Brussel

Phase 4 Unknown
15 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡